Herpes Simplex Virus Infection is commonly known as herpes. The two types of herpes simplex virus (HSV) are HSV-1 (known to cause orofacial disease such as cold sores) and HSV-2 (causes genital infections). Over 80% of herpes infections is asymptomatic. Symptomatic infections are presented with blistering sores, pain during urination, swollen lymph nodes, and fever. The period of latency and mode of reactivation of HSV is still unclear.

The global Herpes Simplex Virus Infection Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Herpes Simplex Virus Infection Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Herpes Simplex Virus Infection Treatment.

Report Scope

The Herpes Simplex Virus Infection Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Herpes Simplex Virus Infection Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Herpes Simplex Virus Infection Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Herpes Simplex Virus Infection Treatment Market Report

Report Metric	Details
Report Name	Herpes Simplex Virus Infection Treatment Market
CAGR	5%
By Type	Herpes Simplex Virus-1 (HSV-1) Infection Herpes Simplex Virus-2 (HSV-2) Infection HSV1 & HSV2 Co-infection By Route of Administration Oral Parenteral By Drug Molecule Small Molecule Vaccine
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	F. Hoffmann-La Roche Ltd, Sanofi, Teva Pharmaceuticals Inc, Merck & Co., Inc, Apotex Inc, Viatris, Epi Health LLC, Zydus Pharmaceuticals, GlaxoSmithKline LLC, Carlsbad Tech, Avet Pharmaceuticals Inc, Glenmark Pharmaceuticals, Fresenius Kabi, Agenus, Inc, Maruho Co. Ltd, AiCuris Anti-infective Cures GmbH
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Herpes Simplex Virus Infection Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Herpes Simplex Virus Infection Treatment Market report?

Ans: The main players in the Herpes Simplex Virus Infection Treatment Market are F. Hoffmann-La Roche Ltd, Sanofi, Teva Pharmaceuticals Inc, Merck & Co., Inc, Apotex Inc, Viatris, Epi Health LLC, Zydus Pharmaceuticals, GlaxoSmithKline LLC, Carlsbad Tech, Avet Pharmaceuticals Inc, Glenmark Pharmaceuticals, Fresenius Kabi, Agenus, Inc, Maruho Co. Ltd, AiCuris Anti-infective Cures GmbH

What are the Application segmentation covered in the Herpes Simplex Virus Infection Treatment Market report?

Ans: The Applications covered in the Herpes Simplex Virus Infection Treatment Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Herpes Simplex Virus Infection Treatment Market report?

Ans: The Types covered in the Herpes Simplex Virus Infection Treatment Market report are Herpes Simplex Virus-1 (HSV-1) Infection, Herpes Simplex Virus-2 (HSV-2) Infection, HSV1 & HSV2 Co-infection, By Route of Administration, Oral, Parenteral, By Drug Molecule, Small Molecule, Vaccine

1 Report Overview

1.1 Study Scope

1.2 Market Analysis By Type

1.2.1 Global Herpes Simplex Virus Infection Treatment Market Size Growth Rate By Type: 2019 VS 2023 VS 2030

1.2.2 Herpes Simplex Virus-1 (HSV-1) Infection

1.2.3 Herpes Simplex Virus-2 (HSV-2) Infection

1.2.4 HSV1 & HSV2 Co-infection

1.3 Market by Application

1.3.1 Global Herpes Simplex Virus Infection Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Herpes Simplex Virus Infection Treatment Market Perspective (2019-2030)

2.2 Herpes Simplex Virus Infection Treatment Growth Trends by Region

2.2.1 Global Herpes Simplex Virus Infection Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Herpes Simplex Virus Infection Treatment Historic Market Size by Region (2019-2024)

2.2.3 Herpes Simplex Virus Infection Treatment Forecasted Market Size by Region (2025-2030)

2.3 Herpes Simplex Virus Infection Treatment Market Dynamics

2.3.1 Herpes Simplex Virus Infection Treatment Industry Trends

2.3.2 Herpes Simplex Virus Infection Treatment Market Drivers

2.3.3 Herpes Simplex Virus Infection Treatment Market Challenges

2.3.4 Herpes Simplex Virus Infection Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Herpes Simplex Virus Infection Treatment Players by Revenue

3.1.1 Global Top Herpes Simplex Virus Infection Treatment Players by Revenue (2019-2024)

3.1.2 Global Herpes Simplex Virus Infection Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Herpes Simplex Virus Infection Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Herpes Simplex Virus Infection Treatment Revenue

3.4 Global Herpes Simplex Virus Infection Treatment Market Concentration Ratio

3.4.1 Global Herpes Simplex Virus Infection Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Herpes Simplex Virus Infection Treatment Revenue in 2023

3.5 Herpes Simplex Virus Infection Treatment Key Players Head office and Area Served

3.6 Key Players Herpes Simplex Virus Infection Treatment Product Solution and Service

3.7 Date of Enter into Herpes Simplex Virus Infection Treatment Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Herpes Simplex Virus Infection Treatment Breakdown Data by Type

4.1 Global Herpes Simplex Virus Infection Treatment Historic Market Size by Type (2019-2024)

4.2 Global Herpes Simplex Virus Infection Treatment Forecasted Market Size by Type (2025-2030)

5 Herpes Simplex Virus Infection Treatment Breakdown Data by Application

5.1 Global Herpes Simplex Virus Infection Treatment Historic Market Size by Application (2019-2024)

5.2 Global Herpes Simplex Virus Infection Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Herpes Simplex Virus Infection Treatment Market Size (2019-2030)

6.2 North America Herpes Simplex Virus Infection Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Herpes Simplex Virus Infection Treatment Market Size by Country (2019-2024)

6.4 North America Herpes Simplex Virus Infection Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Herpes Simplex Virus Infection Treatment Market Size (2019-2030)

7.2 Europe Herpes Simplex Virus Infection Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Herpes Simplex Virus Infection Treatment Market Size by Country (2019-2024)

7.4 Europe Herpes Simplex Virus Infection Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size (2019-2030)

8.2 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Herpes Simplex Virus Infection Treatment Market Size (2019-2030)

9.2 Latin America Herpes Simplex Virus Infection Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Herpes Simplex Virus Infection Treatment Market Size by Country (2019-2024)

9.4 Latin America Herpes Simplex Virus Infection Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size (2019-2030)

10.2 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 F. Hoffmann-La Roche Ltd

11.1.1 F. Hoffmann-La Roche Ltd Company Detail

11.1.2 F. Hoffmann-La Roche Ltd Business Overview

11.1.3 F. Hoffmann-La Roche Ltd Herpes Simplex Virus Infection Treatment Introduction

11.1.4 F. Hoffmann-La Roche Ltd Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024)

11.1.5 F. Hoffmann-La Roche Ltd Recent Development

11.2 Sanofi

11.2.1 Sanofi Company Detail

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Herpes Simplex Virus Infection Treatment Introduction

11.2.4 Sanofi Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024)

11.2.5 Sanofi Recent Development

11.3 Teva Pharmaceuticals Inc

11.3.1 Teva Pharmaceuticals Inc Company Detail

11.3.2 Teva Pharmaceuticals Inc Business Overview

11.3.3 Teva Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Introduction

11.3.4 Teva Pharmaceuticals Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024)

11.3.5 Teva Pharmaceuticals Inc Recent Development

11.4 Merck & Co., Inc

11.4.1 Merck & Co., Inc Company Detail

11.4.2 Merck & Co., Inc Business Overview

11.4.3 Merck & Co., Inc Herpes Simplex Virus Infection Treatment Introduction

11.4.4 Merck & Co., Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024)

11.4.5 Merck & Co., Inc Recent Development

11.5 Apotex Inc

11.5.1 Apotex Inc Company Detail

11.5.2 Apotex Inc Business Overview

11.5.3 Apotex Inc Herpes Simplex Virus Infection Treatment Introduction

11.5.4 Apotex Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024)

11.5.5 Apotex Inc Recent Development

11.6 Viatris

11.6.1 Viatris Company Detail

11.6.2 Viatris Business Overview

11.6.3 Viatris Herpes Simplex Virus Infection Treatment Introduction

11.6.4 Viatris Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024)

11.6.5 Viatris Recent Development

11.7 Epi Health LLC

11.7.1 Epi Health LLC Company Detail

11.7.2 Epi Health LLC Business Overview

11.7.3 Epi Health LLC Herpes Simplex Virus Infection Treatment Introduction

11.7.4 Epi Health LLC Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024)

11.7.5 Epi Health LLC Recent Development

11.8 Zydus Pharmaceuticals

11.8.1 Zydus Pharmaceuticals Company Detail

11.8.2 Zydus Pharmaceuticals Business Overview

11.8.3 Zydus Pharmaceuticals Herpes Simplex Virus Infection Treatment Introduction

11.8.4 Zydus Pharmaceuticals Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024)

11.8.5 Zydus Pharmaceuticals Recent Development

11.9 GlaxoSmithKline LLC

11.9.1 GlaxoSmithKline LLC Company Detail

11.9.2 GlaxoSmithKline LLC Business Overview

11.9.3 GlaxoSmithKline LLC Herpes Simplex Virus Infection Treatment Introduction

11.9.4 GlaxoSmithKline LLC Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024)

11.9.5 GlaxoSmithKline LLC Recent Development

11.10 Carlsbad Tech

11.10.1 Carlsbad Tech Company Detail

11.10.2 Carlsbad Tech Business Overview

11.10.3 Carlsbad Tech Herpes Simplex Virus Infection Treatment Introduction

11.10.4 Carlsbad Tech Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024)

11.10.5 Carlsbad Tech Recent Development

11.11 Avet Pharmaceuticals Inc

11.11.1 Avet Pharmaceuticals Inc Company Detail

11.11.2 Avet Pharmaceuticals Inc Business Overview

11.11.3 Avet Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Introduction

11.11.4 Avet Pharmaceuticals Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024)

11.11.5 Avet Pharmaceuticals Inc Recent Development

11.12 Glenmark Pharmaceuticals

11.12.1 Glenmark Pharmaceuticals Company Detail

11.12.2 Glenmark Pharmaceuticals Business Overview

11.12.3 Glenmark Pharmaceuticals Herpes Simplex Virus Infection Treatment Introduction

11.12.4 Glenmark Pharmaceuticals Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024)

11.12.5 Glenmark Pharmaceuticals Recent Development

11.13 Fresenius Kabi

11.13.1 Fresenius Kabi Company Detail

11.13.2 Fresenius Kabi Business Overview

11.13.3 Fresenius Kabi Herpes Simplex Virus Infection Treatment Introduction

11.13.4 Fresenius Kabi Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024)

11.13.5 Fresenius Kabi Recent Development

11.14 Agenus, Inc

11.14.1 Agenus, Inc Company Detail

11.14.2 Agenus, Inc Business Overview

11.14.3 Agenus, Inc Herpes Simplex Virus Infection Treatment Introduction

11.14.4 Agenus, Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024)

11.14.5 Agenus, Inc Recent Development

11.15 Maruho Co. Ltd

11.15.1 Maruho Co. Ltd Company Detail

11.15.2 Maruho Co. Ltd Business Overview

11.15.3 Maruho Co. Ltd Herpes Simplex Virus Infection Treatment Introduction

11.15.4 Maruho Co. Ltd Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024)

11.15.5 Maruho Co. Ltd Recent Development

11.16 AiCuris Anti-infective Cures GmbH

11.16.1 AiCuris Anti-infective Cures GmbH Company Detail

11.16.2 AiCuris Anti-infective Cures GmbH Business Overview

11.16.3 AiCuris Anti-infective Cures GmbH Herpes Simplex Virus Infection Treatment Introduction

11.16.4 AiCuris Anti-infective Cures GmbH Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024)

11.16.5 AiCuris Anti-infective Cures GmbH Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

F Hoffmann La Roche Ltd

Sanofi

Teva Pharmaceuticals Inc

Zydus Pharmaceuticals

GlaxoSmithKline PLC

Carlsbad Tech

Avet Pharmaceuticals Inc.

Glenmark Pharmaceuticals

Fresenius Kabi

Agenus

Maruho

AiCuris Anti-infective Cures GmbH

List of Tables

Table 1. Global Herpes Simplex Virus Infection Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Herpes Simplex Virus-1 (HSV-1) Infection

Table 3. Key Players of Herpes Simplex Virus-2 (HSV-2) Infection

Table 4. Key Players of HSV1 & HSV2 Co-infection

Table 5. Global Herpes Simplex Virus Infection Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Herpes Simplex Virus Infection Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Herpes Simplex Virus Infection Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Herpes Simplex Virus Infection Treatment Market Share by Region (2019-2024)

Table 9. Global Herpes Simplex Virus Infection Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Herpes Simplex Virus Infection Treatment Market Share by Region (2025-2030)

Table 11. Herpes Simplex Virus Infection Treatment Market Trends

Table 12. Herpes Simplex Virus Infection Treatment Market Drivers

Table 13. Herpes Simplex Virus Infection Treatment Market Challenges

Table 14. Herpes Simplex Virus Infection Treatment Market Restraints

Table 15. Global Herpes Simplex Virus Infection Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Herpes Simplex Virus Infection Treatment Market Share by Players (2019-2024)

Table 17. Global Top Herpes Simplex Virus Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Simplex Virus Infection Treatment as of 2023)

Table 18. Ranking of Global Top Herpes Simplex Virus Infection Treatment Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Herpes Simplex Virus Infection Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Herpes Simplex Virus Infection Treatment Product Solution and Service

Table 22. Date of Enter into Herpes Simplex Virus Infection Treatment Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Herpes Simplex Virus Infection Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Herpes Simplex Virus Infection Treatment Revenue Market Share by Type (2019-2024)

Table 26. Global Herpes Simplex Virus Infection Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Herpes Simplex Virus Infection Treatment Revenue Market Share by Type (2025-2030)

Table 28. Global Herpes Simplex Virus Infection Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Herpes Simplex Virus Infection Treatment Revenue Market Share by Application (2019-2024)

Table 30. Global Herpes Simplex Virus Infection Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Herpes Simplex Virus Infection Treatment Revenue Market Share by Application (2025-2030)

Table 32. North America Herpes Simplex Virus Infection Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Herpes Simplex Virus Infection Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Herpes Simplex Virus Infection Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Herpes Simplex Virus Infection Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Herpes Simplex Virus Infection Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Herpes Simplex Virus Infection Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Herpes Simplex Virus Infection Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Herpes Simplex Virus Infection Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Herpes Simplex Virus Infection Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 47. F. Hoffmann-La Roche Ltd Company Detail

Table 48. F. Hoffmann-La Roche Ltd Business Overview

Table 49. F. Hoffmann-La Roche Ltd Herpes Simplex Virus Infection Treatment Product

Table 50. F. Hoffmann-La Roche Ltd Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)

Table 51. F. Hoffmann-La Roche Ltd Recent Development

Table 52. Sanofi Company Detail

Table 53. Sanofi Business Overview

Table 54. Sanofi Herpes Simplex Virus Infection Treatment Product

Table 55. Sanofi Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)

Table 56. Sanofi Recent Development

Table 57. Teva Pharmaceuticals Inc Company Detail

Table 58. Teva Pharmaceuticals Inc Business Overview

Table 59. Teva Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Product

Table 60. Teva Pharmaceuticals Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)

Table 61. Teva Pharmaceuticals Inc Recent Development

Table 62. Merck & Co., Inc Company Detail

Table 63. Merck & Co., Inc Business Overview

Table 64. Merck & Co., Inc Herpes Simplex Virus Infection Treatment Product

Table 65. Merck & Co., Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)

Table 66. Merck & Co., Inc Recent Development

Table 67. Apotex Inc Company Detail

Table 68. Apotex Inc Business Overview

Table 69. Apotex Inc Herpes Simplex Virus Infection Treatment Product

Table 70. Apotex Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)

Table 71. Apotex Inc Recent Development

Table 72. Viatris Company Detail

Table 73. Viatris Business Overview

Table 74. Viatris Herpes Simplex Virus Infection Treatment Product

Table 75. Viatris Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)

Table 76. Viatris Recent Development

Table 77. Epi Health LLC Company Detail

Table 78. Epi Health LLC Business Overview

Table 79. Epi Health LLC Herpes Simplex Virus Infection Treatment Product

Table 80. Epi Health LLC Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)

Table 81. Epi Health LLC Recent Development

Table 82. Zydus Pharmaceuticals Company Detail

Table 83. Zydus Pharmaceuticals Business Overview

Table 84. Zydus Pharmaceuticals Herpes Simplex Virus Infection Treatment Product

Table 85. Zydus Pharmaceuticals Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)

Table 86. Zydus Pharmaceuticals Recent Development

Table 87. GlaxoSmithKline LLC Company Detail

Table 88. GlaxoSmithKline LLC Business Overview

Table 89. GlaxoSmithKline LLC Herpes Simplex Virus Infection Treatment Product

Table 90. GlaxoSmithKline LLC Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)

Table 91. GlaxoSmithKline LLC Recent Development

Table 92. Carlsbad Tech Company Detail

Table 93. Carlsbad Tech Business Overview

Table 94. Carlsbad Tech Herpes Simplex Virus Infection Treatment Product

Table 95. Carlsbad Tech Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)

Table 96. Carlsbad Tech Recent Development

Table 97. Avet Pharmaceuticals Inc Company Detail

Table 98. Avet Pharmaceuticals Inc Business Overview

Table 99. Avet Pharmaceuticals Inc Herpes Simplex Virus Infection Treatment Product

Table 100. Avet Pharmaceuticals Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)

Table 101. Avet Pharmaceuticals Inc Recent Development

Table 102. Glenmark Pharmaceuticals Company Detail

Table 103. Glenmark Pharmaceuticals Business Overview

Table 104. Glenmark Pharmaceuticals Herpes Simplex Virus Infection Treatment Product

Table 105. Glenmark Pharmaceuticals Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)

Table 106. Glenmark Pharmaceuticals Recent Development

Table 107. Fresenius Kabi Company Detail

Table 108. Fresenius Kabi Business Overview

Table 109. Fresenius Kabi Herpes Simplex Virus Infection Treatment Product

Table 110. Fresenius Kabi Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)

Table 111. Fresenius Kabi Recent Development

Table 112. Agenus, Inc Company Detail

Table 113. Agenus, Inc Business Overview

Table 114. Agenus, Inc Herpes Simplex Virus Infection Treatment Product

Table 115. Agenus, Inc Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)

Table 116. Agenus, Inc Recent Development

Table 117. Maruho Co. Ltd Company Detail

Table 118. Maruho Co. Ltd Business Overview

Table 119. Maruho Co. Ltd Herpes Simplex Virus Infection Treatment Product

Table 120. Maruho Co. Ltd Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)

Table 121. Maruho Co. Ltd Recent Development

Table 122. AiCuris Anti-infective Cures GmbH Company Detail

Table 123. AiCuris Anti-infective Cures GmbH Business Overview

Table 124. AiCuris Anti-infective Cures GmbH Herpes Simplex Virus Infection Treatment Product

Table 125. AiCuris Anti-infective Cures GmbH Revenue in Herpes Simplex Virus Infection Treatment Business (2019-2024) & (US$ Million)

Table 126. AiCuris Anti-infective Cures GmbH Recent Development

Table 127. Research Programs/Design for This Report

Table 128. Key Data Information from Secondary Sources

Table 129. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Herpes Simplex Virus Infection Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Herpes Simplex Virus Infection Treatment Market Share by Type: 2023 VS 2030

Figure 3. Herpes Simplex Virus-1 (HSV-1) Infection Features

Figure 4. Herpes Simplex Virus-2 (HSV-2) Infection Features

Figure 5. HSV1 & HSV2 Co-infection Features

Figure 6. Global Herpes Simplex Virus Infection Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Herpes Simplex Virus Infection Treatment Market Share by Application: 2023 VS 2030

Figure 8. Hospital Pharmacies Case Studies

Figure 9. Retail Pharmacies Case Studies

Figure 10. Online Pharmacies Case Studies

Figure 11. Herpes Simplex Virus Infection Treatment Report Years Considered

Figure 12. Global Herpes Simplex Virus Infection Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Herpes Simplex Virus Infection Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Herpes Simplex Virus Infection Treatment Market Share by Region: 2023 VS 2030

Figure 15. Global Herpes Simplex Virus Infection Treatment Market Share by Players in 2023

Figure 16. Global Top Herpes Simplex Virus Infection Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herpes Simplex Virus Infection Treatment as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Herpes Simplex Virus Infection Treatment Revenue in 2023

Figure 18. North America Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Herpes Simplex Virus Infection Treatment Market Share by Country (2019-2030)

Figure 20. United States Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Herpes Simplex Virus Infection Treatment Market Share by Country (2019-2030)

Figure 24. Germany Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Herpes Simplex Virus Infection Treatment Market Share by Region (2019-2030)

Figure 32. China Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Herpes Simplex Virus Infection Treatment Market Share by Country (2019-2030)

Figure 40. Mexico Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Herpes Simplex Virus Infection Treatment Market Share by Country (2019-2030)

Figure 44. Turkey Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Herpes Simplex Virus Infection Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)

Figure 47. Sanofi Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)

Figure 48. Teva Pharmaceuticals Inc Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)

Figure 49. Merck & Co., Inc Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)

Figure 50. Apotex Inc Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)

Figure 51. Viatris Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)

Figure 52. Epi Health LLC Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)

Figure 53. Zydus Pharmaceuticals Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)

Figure 54. GlaxoSmithKline LLC Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)

Figure 55. Carlsbad Tech Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)

Figure 56. Avet Pharmaceuticals Inc Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)

Figure 57. Glenmark Pharmaceuticals Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)

Figure 58. Fresenius Kabi Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)

Figure 59. Agenus, Inc Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)

Figure 60. Maruho Co. Ltd Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)

Figure 61. AiCuris Anti-infective Cures GmbH Revenue Growth Rate in Herpes Simplex Virus Infection Treatment Business (2019-2024)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions